---
title: "Baolingbao Biology Co.,Ltd. (002286.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002286.SZ.md"
symbol: "002286.SZ"
name: "Baolingbao Biology Co.,Ltd."
industry: "Packaged Foods and Meats"
datetime: "2026-03-03T13:42:23.854Z"
locales:
  - [en](https://longbridge.com/en/quote/002286.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002286.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002286.SZ.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002286.SZ.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002286.SZ.md)


# Baolingbao Biology Co.,Ltd. (002286.SZ)

## Company Overview

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, including oligomaltose, fructose syrup, solid corn syrup, maltodextrin, and glucose syrup; and animal nutrition products comprising baolekang and fubaokang. Its products are used in various applications, such as dairy products, drinks, snacks, health products and dietary supplements, candy, special food items, chemicals for daily use, and animal nutrition.

| Item | Detail |
|------|--------|
| Industry | Packaged Foods and Meats |
| Exchange | CN Market |
| Website | [www.blb-cn.com](https://www.blb-cn.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-03-03T04:30:10.000Z

**Overall: B (0.28)**

**Industry**: Packaged Foods and Meats

| Metric | Value |
|--------|-------|
| Industry Ranking | 39 / 137 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 12.64% |  |
| Net Profit YoY | 32.13% |  |
| P/B Ratio | 1.87 |  |
| Dividend Ratio | 0.55% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4128870449.08 |  |
| Revenue | 2704459225.25 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.80% | C |
| Profit Margin | 5.35% | C |
| Gross Margin | 13.68% | D |
| Revenue YoY | 12.64% | B |
| Net Profit YoY | 32.13% | B |
| Total Assets YoY | 2.16% | C |
| Net Assets YoY | 8.23% | B |
| Cash Flow Margin | 1870.14% | A |
| OCF YoY | 12.64% | B |
| Turnover | 1.00 | A |
| Gearing Ratio | 19.47% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Baolingbao Biology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "12.64%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "32.13%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.87",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.55%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4128870449.08",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2704459225.25",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.80%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "5.35%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "13.68%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "12.64%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "32.13%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.16%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.23%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "1870.14%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "12.64%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.00",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "19.47%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.81 | 44/137 | 29.81 | 27.26 | 25.29 |
| PB | 1.75 | 31/137 | 1.94 | 1.74 | 1.55 |
| PS (TTM) | 1.43 | 45/137 | 1.61 | 1.42 | 1.27 |
| Dividend Yield | 0.59% | 87/137 | 0.95% | 0.66% | 0.43% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | GAMBOL PET (301498.SZ) | B | B | A | A | B | A |
| 02 | MUYUAN (002714.SZ) | B | B | B | C | B | B |
| 03 | HAI TIAN (603288.SH) | A | B | B | A | C | B |
| 04 | SHUANGHUI (000895.SZ) | B | C | A | C | B | B |
| 05 | HAID GROUP (002311.SZ) | B | B | A | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-31T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.15 |
| Highest Target | 14.00 |
| Lowest Target | 14.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002286.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002286.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/002286.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002286.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**